GOLDMAN SACHS GROUP INC - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 159 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$4,671,195
+2.1%
209,002
-1.8%
0.00%0.0%
Q2 2023$4,573,438
+62.9%
212,817
+81.8%
0.00%0.0%
Q1 2023$2,807,574
+37.2%
117,031
+32.7%
0.00%
Q4 2022$2,045,961
+23.8%
88,188
-14.5%
0.00%
Q3 2022$1,652,000
+52.5%
103,109
+68.7%
0.00%
Q2 2022$1,083,000
-47.2%
61,121
-39.4%
0.00%
Q1 2022$2,052,000
-25.8%
100,803
-31.9%
0.00%
-100.0%
Q4 2021$2,767,000
-24.2%
148,120
-19.9%
0.00%0.0%
Q3 2021$3,651,000
-12.9%
184,970
+4.3%
0.00%0.0%
Q2 2021$4,193,000
-6.9%
177,385
-6.6%
0.00%0.0%
Q1 2021$4,503,000
+239.1%
189,997
+186.5%
0.00%
Q4 2020$1,328,000
+41.4%
66,319
+47.0%
0.00%
Q3 2020$939,000
-31.3%
45,126
-42.2%
0.00%
Q2 2020$1,367,000
-36.8%
78,131
-41.0%
0.00%
-100.0%
Q1 2020$2,163,000
-57.3%
132,498
-46.2%
0.00%0.0%
Q4 2019$5,065,000
+444.6%
246,153
+204.0%
0.00%
Q3 2019$930,000
-25.0%
80,980
-14.1%
0.00%
Q2 2019$1,240,000
-54.0%
94,271
-47.1%
0.00%
-100.0%
Q1 2019$2,697,000
-26.0%
178,173
-16.0%
0.00%0.0%
Q4 2018$3,643,000
-25.5%
212,157
-36.1%
0.00%0.0%
Q3 2018$4,891,000
+87.5%
331,785
+203.3%
0.00%0.0%
Q2 2018$2,608,000
+84.4%
109,377
+97.6%
0.00%
Q1 2018$1,414,000
-31.6%
55,353
-50.6%
0.00%
Q4 2017$2,068,000
+87.5%
112,024
+6.5%
0.00%
Q3 2017$1,103,000
+20.3%
105,217
+43.5%
0.00%
Q2 2017$917,000
+0.8%
73,310
-18.9%
0.00%
Q1 2017$910,000
+64.0%
90,377
+153.5%
0.00%
Q4 2016$555,000
+150.0%
35,646
+208.7%
0.00%
Q3 2016$222,000
-57.5%
11,546
-73.8%
0.00%
Q2 2016$522,000
-52.3%
44,088
-26.9%
0.00%
Q1 2016$1,094,000
-2.6%
60,294
+47.7%
0.00%
Q4 2015$1,123,000
+55.8%
40,834
+1.0%
0.00%
Q2 2015$721,00040,4300.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders